穴位埋线治疗非酒精性脂肪性肝炎疗效观察

目的:比较穴位埋线与西药治疗非酒精性脂肪性肝炎(NASH)的疗效差异。方法:将60例患者随机分为埋线组和西药组,各30例。埋线组采用穴位埋线治疗,穴取膈俞、肝俞、中脘、气海、足三里、阳陵泉、丰隆;西药组口服凯西莱片,肝功能正常后改服血脂康胶囊治疗。4周为一疗程,连续治疗2个疗程后,观察两组患者治疗前后临床症状、体质量指数(BMI)、肥胖度和谷丙转氨酶(ALT)、天门冬氨酸氨基转移酶(AST)、γ-谷氨酰转肽酶(γ-GT)、总胆固醇(TC)和甘油三酯(TG)值和肝/脾CT比值。结果:两组患者治疗后BMI、肥胖度和血清ALT、AST、γ-GT、TC、TG均明显降低(均P0.05),且埋线组下降更明显(均P0.05);两组患者CT诊断均明显好转,埋线组在肝/脾CT比值改善方面优于西药组(均P0.05);埋线组总有效率90.0%(27/30),西药组总有效率76.7%(23/30),埋线组疗效优于西药组(P0.05)。结论:穴位埋线是治疗非酒精性脂肪性肝炎的有效方法,疗效优于口服凯西莱片和血脂康治疗。

Clinical observation on acupoint catgut embedding for treatment of non-alcoholic steatohepatitis

Abstract: Objective: To observe the Acupoint catgut embedding treatment of non-alcoholic steatohepatitis (NASH) efficacy. Methods: 60 patients with non-alcoholic steatohepatitis patients were randomly divided into treatment group 30 cases treated with acupoint catgut-embedding ,and Control group of 30 cases treated with Tiopronin , with normal liver function was converted into Xuezhikang treatment. 4 weeks for a course of treatment, continuous treatment of 2 courses. Observe clinical symptoms of the two groups before and after treatment, BMI values, degree of obesity and serum ALT, AST, γ-GT, TC, TG, liver / spleen CT ratio. Results: BMI values of two groups after treatment, obesity degree and ALT, AST, γ-GT, TC, TG values were significantly lower (P <0.05),treatment group in the clinical symptoms and liver / spleen CT ratio of improvement than the control group (P <0.05),the total efficiency of treatment group is 90%,the total efficiency of control group is 76.67%, the treatment group more effective than the control group (P <0.05). Conclusion: Acupoint catgut embedding is an effective method for treatment of non-alcoholic steatohepatitis.